주식/증권 📉 부정적

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

MarketWatch - Top Stories 2026/08/27 08:37:00 10회

요약

While Ozempic maker Novo Nordisk has fallen on tough times, Wall Street analysts have still been reluctant to advise investors to sell the stock, until Deutsche Bank lowered the boom on Thursday.

원문 기사 보기

관련 뉴스

Here are the key things Fed Chairman Kevin Warsh said — and didn’t say — while Americans were sleeping Thursday night

2026/10/16

Stock Market: Will S&P 500 Open Up or Down Today?

2026/10/16

Taiwan plans $4B Texas hub for AI, Nvidia suppliers

2026/10/16

Anthropic investors discuss $1.5T valuation, $500B below prior expectations - report

2026/10/16

뉴스 목록으로